Pocketalk Inc.'s European Subsidiary Achieves First Quarterly Operating Profit

Pocketalk Inc.'s European subsidiary, POCKETALK B.V., achieved its first quarterly operating profit in Q1 2026 (January-March). This was a result of optimizing sales systems and reviewing cost structures, leading to increased adoption of the 'Pocketalk' AI translation device, particularly in the medical sector.
その他NQ 42/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 7, 2026 at 19:00
  • 🔍 Collected: April 7, 2026 at 10:31
  • 🤖 AI Analyzed: April 21, 2026 at 00:22 (325h 50m after Collected)
Pocketalk Inc. (Head Office: 7-1 Nihonbashi Kabutocho, Chuo-ku, Tokyo; Representative Director and President: Noriyuki Matsuda) announces that its European subsidiary (hereinafter, 'POCKETALK B.V.') achieved its first operating profit in its quarterly performance (January-March 2026).

This quarterly operating profit was achieved by establishing a business foundation capable of consistently generating profits, through the optimization of sales systems and review of cost structures pursued to date. Specifically, improved sales efficiency through the development of a distributor network, coupled with rationalization of personnel structures and promotion expenses, enabled highly profitable business operations.
This quarterly operating profit is the result of improved revenue structures, achieved through these initiatives, functioning stably over a certain period.

In Europe, the movement of people with diverse linguistic and cultural backgrounds is active, and the importance of multilingual support is growing, particularly in medical institutions and public service settings. Language barriers are a critical issue affecting the quality and safety of services, and the need for solutions is increasing in various countries.

In this environment, our company is committed to creating an environment where everyone can communicate in their native language through the AI translation 'Pocketalk' series. In Europe, following the completion of evaluations for medical institutions in the UK (DTAC / DCB0129), adoption has progressed, primarily in the medical field. Currently, it has been introduced in over 300 medical and welfare-related facilities. Furthermore, after obtaining DTAC certification, the number of orders has grown by more than 2.5 times, demonstrating a clear rise in demand.

Going forward, POCKETALK B.V. aims for stable growth by continuing operations that prioritize efficiency and profitability, while focusing on high-demand areas such as the medical field.

Pocketalk Inc. is committed to its mission of 'eliminating language barriers,' expanding the provision of the 'Pocketalk' series globally to realize a world where people can communicate in their native languages and understand each other deeply. Moving forward, we will continue to promote business development tailored to the characteristics of each region, while responding to the growing multilingual support needs worldwide.

## What is the AI translation device 'Pocketalk S2'?

The 'Pocketalk S2' is the latest model launched in October 2024. It can translate 91 languages into audio and text, and one language into text only. Compared to previous models, the range of countries and regions where communication is possible without Wi-Fi has expanded, and it features built-in mobile communication capabilities that can be used in over 170 countries and regions worldwide without Wi-Fi. Furthermore, battery life has been significantly improved, updating the device for use in all scenarios.
Security has also been further strengthened through integration with 'Pocketalk Analytics,' and by complying with global security standards, it can be used with confidence not only by individuals but also by corporations, organizations, and local governments.
For details, visit URL: https://pocketalk.jp/device